Patient safety
At HIMSS23, panelists discuss how providers can boost transparency and patient trust in the healthcare system.
Amid a device recall and supply chain struggles, the health tech giant said it would cut more jobs by 2025.
CEO of Kami Vision Yamin Durrani talks about the company's new fall-detection AI technology for elder care. It employs home cameras to alert for a fall, then routes notices to concerned parties, while considering privacy.
A review of studies published in npj Digital Medicine found diagnostic and triage accuracy varied but was generally low, raising concerns about using symptom checkers as patient-facing tools.
Dozee's sensor-based technology uses AI to track vital parameters.
Ramakant Vempati, Wysa cofounder and president, discusses how the startup tests its AI-backed chatbot to monitor safety and quality.
The program comes a week after the digital mental health company replaced its CEO.
Cerebral is halting prescriptions such as Adderall and Xanax for current and new patients.
The suspension comes as the digital mental health company faces increasing pressure over its prescription practices, particularly for ADHD medications.
Former vice president Matthew Truebe said he was fired after raising concerns about the company's prescribing practices, alleging Cerebral aimed to prescribe stimulants to all its ADHD patients to increase retention.